Connect
MJA
MJA

Gains in neurotrauma research activity and output associated with a Victorian state government funding program

Alex Collie
Med J Aust 2010; 192 (12): 712-714. || doi: 10.5694/j.1326-5377.2010.tb03709.x
Published online: 21 June 2010

Traumatic brain and spinal cord injuries are debilitating and have lifelong impacts on the injured person. Aside from the physical impact of these injuries, many aspects of the person’s daily function are affected, including the ability to work and take part in social and community activities. Advances in treatment have led to a reduction in mortality, meaning that an increasing majority of those affected are living with the consequences of traumatic brain injury (TBI) or spinal cord injury (SCI) for decades after injury.

There are an estimated 1493 new cases of moderate TBI and 1000 new cases of severe TBI per year in Australia, and an estimated 137 new cases of paraplegia and 136 new cases of quadriplegia.1 Despite the relatively low incidence of these injuries, they impose a large economic burden, with the total lifetime cost of new cases in 2008 estimated to be $8.6 billion for moderate and severe TBI and $2 billion for traumatic SCI.1 In 2005, the Victorian government established the Victorian Neurotrauma Initiative (VNI), a health and medical research fund to support research in these areas. The VNI was established with an initial 5-year time frame and a budget of $63 million to commit to projects before 30 June 2010.

Health and medical research funding agencies are increasingly concerned with measuring outputs and outcomes from the research they support, in order to demonstrate return on investment and to justify continued or increased investment. Evaluation of research outcomes may also provide valuable insight into the most effective funding mechanisms and allow the value delivered by different funding agencies to be compared.

In this context, research agencies typically attempt to determine the extent to which their activities contribute to gains in knowledge, wealth and health.2,3 Knowledge gains are the easiest to measure (eg, via bibliometric analyses) and have received the most attention. Furthermore, knowledge gains become apparent sooner than health benefits and commercial returns, and provide a relatively simple method of comparing outcomes between research funding agencies.4 A number of Australian funding agencies have published analyses of their funding programs.3-5 These have focused on knowledge gain as measured by research publications and other bibliometric outcomes. Economic and commercial payback from research investment in the Australian Government’s Cooperative Research Centres has also been evaluated.6

In this article, I report the results of an evaluation conducted 3 years after the launch of the VNI. The focus of the evaluation was to determine the state of neurotrauma research activity within Victoria before and 3 years after the establishment of the VNI; it included a focus on knowledge gains and research capacity.

Survey results
Summary of funding rounds

Two project grant funding rounds were completed in the first 3 years of the VNI’s operations, and were the focus of this analysis. VNI funding is nationally competitive but must include a substantial Victorian component. During these two funding rounds, the VNI received 147 applications requesting a total of $68.4 million in funding. Of these, 34 successful applications (23%) received funding to the value of $18.6 million (27%). Funding decisions for the first and second project grant rounds were reached in May 2006 and June 2007, respectively. As an indication of scale, the National Health and Medical Research Council (NHMRC) awarded 35 traumatic brain injury and spinal cord injury project grants to the value of $13.8 million in 2005 and 2006 (note that this sum includes funds for all grant subtypes). Of these, 11 grants to the value of $3.8 million were awarded to Victorian institutions. The VNI contribution represents a near fivefold increase in the amount of competitive funding for neurotrauma research in the state of Victoria during this period. Since June 2008, much of the remaining funding has been allocated, with about $13 million unallocated as at September 2009.

Of the projects awarded VNI grants, eight were focused on SCI, 23 on TBI and the remaining three had a joint brain and spinal cord injury focus. Thirty-two percent (11/34) of awarded projects focused on clinical management; 26% (9/34) on rehabilitation and disability management; 32% (11/34) on biomedical science; and 9% (3/34) on technological developments. The average value of approved grants was $547 947. Thirty projects were of 36 months’ duration, with one of the remaining two of 12 months’ duration and the other of 24 months’ duration.

Survey outcome data

Twenty-seven of 29 laboratories (93%) receiving VNI funding responded to the survey. Of these, 17 were undertaking neurotrauma research at the beginning of the survey period (1 July 2005). The 27 laboratories included in the second sample (ie, undertaking neurotrauma research at the end of the period [1 July 2008]) received 32 of the 34 project grants approved by the VNI during the period.

Substantial self-reported changes in measures of research activity and capacity were recorded between 1 July 2005 and 1 July 2008 (Box 1 and Box 2). These included a 110% increase in the number of individual researchers working in Victoria (Box 1); the attraction of 72 new staff to the area of neurotrauma research, including 27 who moved from interstate to begin work in Victoria during the period (Box 1); and a 186% increase in total collaborative activity (Box 2).

Similar changes in research output were observed over the period. Comparison of outputs in the year 2007–2008 with those in the year 2004–2005 showed a 196% increase in the number of refereed journal articles (Box 1); a near doubling of the number of presentations given by research staff (Box 1); a 193% increase in funding attracted from all sources (Box 2); and a 200% increase in the number of clinical policies and guidelines incorporating Victorian research outcomes (Box 2).

The data also indicated substantial differences in the magnitude of neurotrauma research activity when laboratories in Victoria were compared. For example, the number of staff employed in individual research groups at 1 July 2008 ranged from one to 44 (Box 1), while at the same time point the amount of funding from all sources received in the past 12 months ranged from $12 000 to $3.4 million (Box 2).

Discussion

Prior analysis of the effects of health and medical research funding has indicated that open competitive grant schemes can make a significant contribution to knowledge creation, conventionally measured by scientific publication rate.3,7-9 However, there is as yet no consensus regarding the most appropriate measures of the impact of research funding activities. Within Australia, nationally competitive grant schemes have used outcome measures such as average grant expenditure per scientific publication,3 number of publications per grant4 and measures of workforce capacity.6 These approaches, while facilitating some measure of comparability between grant schemes, do not address other arguably more important outcomes of research funding, including research capacity and translation of research findings into practice. Recently, the NHMRC published outcomes from analyses of end-of-grant reports, including an increased focus on collaborative activity, research training and commercialisation.5 These studies represent an important benchmark against which future performance can be measured.

The data presented here demonstrate substantial increases in neurotrauma research activity and output within the state of Victoria, occurring concurrently with the first 3 years of the VNI’s operations. These changes were evident on measures of research collaboration, workforce capacity, research output, economic and commercial activity and research translation (Box 1 and Box 2).

While it is not possible to imply a causal relationship between research funding provided through the VNI and the observed outcomes, no other significant brain and spinal cord injury research funding initiatives were undertaken in Victoria during the period of this study. Therefore, it is likely that the observed changes are at least partly a consequence of the activities of the VNI.

Australian experience suggests that gains in health and wealth arising from medical research funding require at least 7 years from time of grant receipt to be realised.3,6 The current results suggest that the Victorian neurotrauma research sector is on track to achieve these important outcomes within this expected time frame.

2 Comparison of measures of research activity in neurotrauma in Victoria at 1 July 2005 and 1 July 2008

1 July 2005


1 July 2008


Change


Output

Total

Mean*

Min

Max

Total

Mean*

Min

Max

Total

%


Number of laboratories researching neurotrauma

17

27

10

59

Research collaboration

Number of individual collaborators

71

4.2

0

15

203

7.5

1

31

132

186

Number of Victorian collaborators

44

2.6

0

12

103

3.8

0

22

59

134

Number of interstate collaborators

17

1.0

0

9

53

2.0

0

17

36

212

Number of international collaborators

10

0.6

0

2

48

1.8

0

9

38

380

Economic and commercial activity

Funding from all sources in past 12 months ($ thousand)

5600

329

0

1650

16 380

607

12

3422

10 780

193

Number of patents filed

3

0.2

0

1

7

0.3

0

2

4

133

Number of commercial initiatives§

27

1.6

0

15

55

2.0

0

31

28

104

Research translation

Number of representatives on advisory committees and boards

83

4.9

0

16

143

5.3

0

25

60

72

Number of clinical policies and guidelines incorporating research findings

14

0.8

0

2

42

1.6

0

8

28

200


* Mean per research unit surveyed. † Data refer to individual collaborators on any neurotrauma related project. ‡ Sources include Victorian Neurotrauma Initiative and other funding agencies for neurotrauma related research activities. § Commercial initiatives include contract research activities, technology licensing, spin-off companies and investment by commercial organisations. ¶ Instruments include hospital clinical treatment protocols, health system policies, and Transport Accident Commission and Victorian government funding policies.

  • Alex Collie1

  • Institute for Safety Compensation and Recovery Research, Monash University, Melbourne, VIC.



Acknowledgements: 

I would like to acknowledge the Transport Accident Commission (TAC) health research team for their assistance with data collation.

Competing interests:

I was employed by the TAC during the period the article was written. The TAC provided most of the funding to the VNI, the health and medical research fund that is the subject of the article. I was also Executive Director of the VNI during the period the article was written.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.